# Peptide Display
Orbit Discovery Ltd. is a spin-out from the University of Oxford. Our technology is an enhanced DNA-encoded peptide display technology which was developed at the Weatherall Institute of Molecular Medicine to address the need for a display technology able to probe the cell surface. The initial objective was to present random peptides to T-cells with unknown specificity to establish their epitopes – something that was impossible with phage display or mRNA display.
The technology supports the presentation of natural amino acids, non-natural amino acids, linear peptides, constrained peptides and peptides modified after translation.
Our business model is simple – establish both internal discovery programmes which we will out-license in the future and collaborative programmes with industry and academia. We aim to balance the two through the efficiency that our technology enables and identify well characterised, selective hits for existing and novel drug targets wherever a peptide might make sense.